CVM

CEL-SCI Corp

1.080

-0.030-2.70%

Pre Market: 1.110 +0.030 +2.78%04:00 06/30 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE1.064/1.050

TODAY RANGE1.064-1.170

VOL658.53K

MARKET CAP19.92M

52 WEEK RANGE0.8900-13.48

AVG VOL (3M)465.76K

% TURNOVER3.77%

TURNOVER--

P/E (TTM)-0.3184

% RANGE10.06%

EPS(TTM)-3.5800

P/E(FORWARD)-0.2740

P/B1.408

BVPS0.8095

DIVIDEND--

P/S159.87

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP15.62M

SHARES OUTSTANDING17.48M

NEXT EARNINGS08/12-08/17

FREE FLOAT13.70M

LOT SIZE1

EX-DATE05/20/2025

News

Press Releases

Financial Reports

Profile

TipRanks·06/24 12:11
CEL-SCI, Saudi Amarox hold strategic agreement signing at BIO 2026
TipRanks·06/16 12:14
CEL-SCI highlights dual-track strategy for Multikine
Benzinga·06/16 12:08
CEL-SCI Announces Dual-Track Strategy To Bring Multikine To Patients With Head And Neck Cancer Through Parallel Regulatory Pathways In The U.S. And Saudi Arabia
Seeking Alpha·06/15 08:59
CEL-SCI slides after pricing $2.5M best-efforts common stock offering at $1.00/share
TipRanks·06/12 12:11
CEL-SCI, Saudi Amarox to conduct signing ceremony for strategic agreement
Benzinga·06/12 12:02
CEL‑SCI To Sign Saudi Amarox Deal At BIO International Convention 2026, Advancing Multikine Commercialization In Saudi Arabia
Benzinga·06/11 12:05
12 Health Care Stocks Moving In Thursday's Pre-Market Session
TipRanks·05/19 02:01
Cel-Sci CEO Makes Bold Insider Move Signaling Growing Confidence
TipRanks·05/18 12:10
CEL-SCI reports Q2 EPS (67c) vs. ($2.33) last year
Seeking Alpha·05/18 12:04
Cel-Sci GAAP EPS of -$1.35
Dow Jones·05/18 12:01
*CEL-SCI 2Q Loss $5.5M >CVM
Dow Jones·05/18 12:00
Press Release: CEL-SCI Reports Fiscal Second Quarter 2026 Results
Benzinga·05/15 22:56
CEL-SCI Q2 EPS $(0.67) Down From $(0.08) YoY
TipRanks·05/15 02:06
Cel-Sci Chief Makes Bold Insider Move, Tightening Alignment With Shareholders
TipRanks·05/14 23:34
Cel-Sci Forms Multikine Commercialization Partnership in Middle East

Same Industry

Name/Symbol

Change%

Price

CEL-SCI Corp

CVM

-2.70%

1.080

Regeneron Pharmaceuticals

REGN

-0.17%

631.81

GridAI Tech

GRDX

-1.12%

4.400

BIONTECH

BNTX

+1.36%

91.22

United Therapeutics Corp.

UTHR

-0.13%

542.66

Vertex Pharmaceuticals Inc

VRTX

+2.32%

491.34

Siga Technologie

SIGA

-0.76%

3.920

MRNA

Charles Riv Labs Intl Inc

CRL

+0.54%

226.79

Medpace Holdings

MEDP

+1.37%

527.07

TLPH

ICON plc

ICLR

+5.53%

169.86

China Biologic

CBPO

0.00%

119.99

Iqvia Hldgs Inc

IQV

+2.53%

191.14

MOLECULAR PARTNERS AG

MOLN

-3.31%

3.800

Arcturus Therape

ARCT

-1.47%

6.72

Gilead Sciences Inc

GILD

-1.21%

126.33

PRA Health

PRAH

0.00%

165.21

Incyte Corp

INCY

-1.13%

113.36

Aptevo Therapeutics Inc

APVO

-2.42%

4.440

Biospecifics

BSTC

0.00%

88.53

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.